TITLE

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma

AUTHOR(S)
Liang-He Yu; Nan Li; Shu-Qun Cheng
PUB. DATE
January 2011
SOURCE
International Journal of Hepatology;2011, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer worldwide; despite the curative treatment for HCC, the rate of tumor recurrence after hepatectomy remains high. Tumor recurrence can occur early (<2 years) or late (>2 years) as metastases or de novo tumors. Several tumor factors were associated with HCC recurrence; high hepatitis B virus (HBV) load is the major risk factor for late recurrence of HCC after resection. Preoperative antiviral therapy improves liver function, and postoperative reduce HCC recurrence. In this paper, we focus on antiviral treatment to improve the liver function, prevent recurrence, and lengthen the overall survival for HBV-related HCC.
ACCESSION #
75197879

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics